Page 15 - CUA 2020_Pediatric
P. 15

2020 CUA Abstracts





        Conclusions: UD >4 mm is associated with a higher incidence of FUTI   units had T 1/2 <5 minutes and none had T1/2 >75 minutes (p<0.001). The
        and surgeries when compared to UD ≤ 4mm. Within P2, there is no   ROC curve for T1/2 <5 minutes demonstrated 98 % sensitivity and 51%
        significant difference in surgical intervention or FUTI when comparing   specificity, whereas a T1/2 >75 minutes demonstrated 100% specificity
        UD 4.1–7 mm and >7 mm This leads us to believe that UD >4 mm is a   and 26% sensitivity. Analysis of the GW using a ROC curve revealed that a
        reliable cutoff to define ureteral dilation.         cutoff of 50% GW has 100% specificity and 55% sensitivity for pyeloplasty.
                                                             Conclusions: The modified T1/2 criteria are valid predictors of pyeloplasty
        MP-12.5                                              for AHN. Unfortunately, these criteria exist in only 25% of patients. In the
                                                             remaining 75% of cases, those with indeterminant T1/2, the GW <50%
        Validation of modified diuretic drainage times cutoffs in   was helpful in identifying a further 30% of cases requiring pyeloplasty.
        antenatal hydronephrosis
        Amr Hodhod , Francis Petrella , Mohamed El-Sherbiny , Iman Sadri ,
                                                1
                              1
                                                         1
                  1
        Roman Jednak , J.-P. Capolicchio 1                   MP-12.6
                  1
                                                                               ®
        1 Urology, McGill University Health Centre, Montreal, QC, Canada  Outcomes of Deflux  treatment for vesicoureteral reflux
        Introduction: The value of diuretic renography drainage times in congeni-  following pediatric transplant: A systematic review
        tal hydronephrosis (AHN) decision-making is controversial. Recently, the   Karla Rebullar , Fardod O’Kelly , Martin A. Koyle , Andrew J Kirsch ,
                                                                                                 1
                                                                                                              2
                                                                                    1
                                                                       1
        Washington group suggested a modification to the classically described   Armando J. Lorenzo , Rusul Al-Kutbi , Fadi Zu’bi
                                                                                      1
                                                                           1
        diuretic drainage time cutoffs. They found that a drainage half-time (T1/2)   1 Division of Urology, The Hospital for Sick Children, Toronto, ON,
        <5 minutes is normal whereas a T1/2 exceeded 75 minutes predicts pyelo-  Canada;  Department of Pediatric Urology, Children’s Healthcare of
                                                                    2
        plasty. We sought to evaluate these criteria, and in addition, we investi-  Atlanta, Atlanta, GA, United States
        gated the use of global tracer washout (GW) as a predictor of pyeloplasty.  Introduction: Vesicoureteral reflux (VUR) after renal transplant in the
        Methods: We retrospectively reviewed consecutive pyeloplasties from   pediatric population may be associated with an increased incidence of
        2004–2018 for AHN. Patients who underwent pyeloplasty due to low   urinary tract infection (UTIs) leading to increased morbidity.  The non-
                                                                                                        1
        differential renal function (DRF) <30% or infection were excluded. The   orthotopic location of the transplanted ureter may pose challenges in cor-
        control group comprised grade 3 and 4 AHN managed conservatively.   recting the VUR using endoscopic injection techniques. Herein, we report
        The initial renal ultrasound and MAG 3 Lasix renogram were reviewed   the results of a systematic review evaluating the outcomes of endoscopic
        for SFU grade, DRF, type of renogram curve, T1/2, and GW. A ROC curve   treatment of VUR using Deflux in this population.
        was used to evaluate the T1/2 and GW cutoff points that can predict   Methods: PubMed and Embase databases were searched from October
        pyeloplasty, using a p<0.05.                         2001 to April 2019. Full-text English articles involving patients less than
        Results: The pyeloplasty group consisted of 84 patients (88 renal units) and   18 years old at the time of transplant, with a diagnosis of VUR post-
        the control group consisted of 58 patients (59 renal units). The median   transplantation, who underwent Deflux treatment were included.
        age at pyeloplasty was 4.5 months (0.5–26), while the median followup   Results: We found six eligible studies describing Deflux treatment out-
        of the control group was 19 months (9–43). One renal unit (1.1%) in the   comes in 67 pediatric patients with post-transplant VUR where voiding
        pyeloplasty group had a T1/2 <5 minutes, whereas 26% (23/88) had T 1/2   cystourethrogram (VCUG) confirmed the diagnosis and resolution of VUR.
        >75 minutes (p<0.001) (Table 1). In the control group, 48% (28/59) of   Mean success rate was 36.8%. Ureteral obstruction occurred in seven
         MP-12.5. Table 1. Patients’ demographics and initial renogram data
                                                          Pyeloplasty group       Control group         p
         Patients number (units)                              84 (88)               58 (59)
         Age at presentation median (range)               0.37 mon (0.03–10.9)   0.83 mon (0.07–9.5)  0.002
         Gender                Male n (%)                     63 (75)               45 (77.6)          0.72
                               Female n (%)                   21 (25)               13 (22.4)
         Side                  Male n (%)                     63 (75)               45 (77.6)          0.25
                               Female n (%)                   21 (25)               13 (22.4)
         Laterality            Unilateral n (%)               80 (95.2)             57 (98.3)          0.7
                               Bilateral n (%)                 4 (4.8)               1(1.7)
         SFU at presentation   Grade 3 n (%)                  25 (28.4)             42 (71.2)         <0.001
                               Grade 4 n (%)                  63 (71.6)             17 (28.8)
         Age at renogram median (range)                    1.7 mon (0.3–11)     2.8 mon (0.8–25.2)    0.001
         DRF median (range)                                 46 % (30–100)          51% (34–65)        0.001
         T half median (range)                            30.5 min (3.3–500)     5.4 min (0–51.4)     <0.001
         Global washout median (range)                        46% (0–95)          85% (54–99.4)       <0.001
         T half according to Washington criteria
           <5minutes n (%)                                     1 (1.1)              28 (47.5)         <0.001
           5–75 minutes n (%)                                 64 (72.7)             31 (52.5)
           >75 minutes n (%)                                  23 (26.2)               0
         Global isotope washout
           <50%, n (%)                                        47 (53.4)               0               <0.001
           50–90%, n (%)                                      40 (45.5)             39 (66.1)
           >90%, n (%)                                         1 (1.1)              20 (33.9)



        S152                                    CUAJ • June 2020 • Volume 14, Issue 6(Suppl2)
   10   11   12   13   14   15   16   17   18   19   20